Roche announces positive results for Actemra in phase III study

VIENNA, Nov 13 (Reuters) - Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroid-fre…
Read the full story: Reuters: Healthcare